Obuprazine Schizophrenia Clinical Trial: Phase 2b Data
Obuprazine (TRTL-107) beat placebo at all three doses in a 363-patient Phase 2b trial in China. Key PANSS results, safety gaps and next steps.
Obuprazine (TRTL-107) beat placebo at all three doses in a 363-patient Phase 2b trial in China. Key PANSS results, safety gaps and next steps.